NIH cancels funding for landmark diabetes study

The decision, likely tied to severing of grants at Columbia University, appears at odds with Trump officials' priorities.

March 17, 2025 Check out STAT+

Sponsored By

Wikimedia Commons STAT+ | NIH cancels funding for landmark diabetes study at a time of focus on chronic disease NIH funding for 30-year Diabetes Prevention Program stopped, apparently in connection with Trump administration stoppage of funds to Columbia University. By Elaine Chen WHO issues starkest warning yet on fallout from U.S. withdrawal of aid for global health Tedros Adhanom Ghebreyesus says U.S. has a responsibility to manage the withdrawal in ways that don't endanger the lives of people who rely on the programs. By Helen Branswell STAT+ | At NIH, 'everyone is on edge' as they brace for deep cuts and more centralized control As the NIH expects staff cuts of up to 5,000 of its 20,000 positions, "people are scrambling and freaking out," a researcher said. By Jonathan Wosen, Megan Molteni, Jason Mast, Angus Chen, Lev Facher, and Anil Oza Photo illustration: STAT; Photos: Courtesy of Edigene, BRL Medicine, HuidaGene STAT+ | These 12 Chinese companies are poised to transform CRISPR gene-editing STAT Who to Know series looks at 12 Chinese companies leading the charge in CRISPR gene-editing innovation. By Brian Yang Opinion: Howard Dean: Sympathy, not sanctimony, is the right response to vaccine fears All too often, public health authorities reflexively dismiss people asking good-faith questions about vaccines' safety and efficacy as anti-vaxxers. By Howard Dean STAT+ | New Stanford tool evaluates AI models on tasks that actually matter in health care Stanford researchers have devised a new way to evaluate how well out-of-the-box AI language models perform routine health care tasks. By Brittany Trang Adobe Opinion: HIPAA can't keep up with health care's security crisis The regulatory approach to artificial intelligence in health care security requires particular attention. By Patrick Spencer

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser